← FDA Drug Approvals (Drugs@FDA)

METHYLNALTREXONE BROMIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN LABS LTD · Approved 2025-05-28

Drug application

FDA Application #

ANDA208592

Application type

Abbreviated New Drug Application (Generic)

Brand name

METHYLNALTREXONE BROMIDE

Generic name

Methylnaltrexone Bromide

Active ingredients

METHYLNALTREXONE BROMIDE

Dosage form

SOLUTION

Route

SUBCUTANEOUS

Marketing status

Discontinued

Sponsor

MYLAN LABS LTD

First approval

2025-05-28

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown